cBioMey
Bio-Interactive Structural Delivery for Active Upgrading

Shaohua Ren, Pharmacist, CEO

It is precisely at this bottleneck that cBioMey has developed a ginseng-derived molecular-based active compound delivery system, forming an upgraded platform defined by cBioMey as BISD (Bio-Interactive Structural Delivery). This delivery system transforms the carrier from a mere “transport vehicle” into a functional module with bio-synergistic capabilities. Professor Jiang Zhihong, an internationally renowned natural product pharmacologist and a pioneer in global ginseng research with numerous groundbreaking achievements, is the founder of the technological framework underlying this platform.

Unlike traditional formulation systems that regard delivery as a “supportive measure,” cBioMey approaches it from a dermatopharmacological perspective, viewing it as a prerequisite for active ingredients to enter biological pathways. The skin is not a passive surface but a highly dynamic biological system composed of lipid structures, keratinocytes, immune cells, and the follicular microenvironment. Any functional active ingredient can only produce verifiable efficacy after reaching the correct spatial location and participating in the corresponding signaling pathways.

cBioMey’s core innovation lies in the development of novel nano-delivery modules, BISD, using rare ginsenosides, replacing the cholesterol component with naturally derived molecular structures. This approach enhances transdermal and transmembrane functions while introducing targeted regulation and synergistic mechanisms.

Innovative Structural Delivery of Ginseng Molecules to Replace Cholesterol

In classical liposomes and membrane mimetic systems, cholesterol is a critical component for maintaining membrane structural stability and fluidity. However, cBioMey has engineered a natural alternative by systematically screening and reconstructing the molecular structures of ginsenosides, which demonstrates a high degree of compatibility with cholesterol in terms of spatial configuration and membrane phase.

This design is not merely a material substitution; rather, it is grounded in two biological foundations:

First, the stratum corneum lipid structure and the cell membrane are rich in cholesterol. The introduction of structural similarity enhances the affinity of ginsenoside nanocarriers for the stratum corneum and cell membrane environments, significantly reducing the transmembrane energy barrier.

From Simple Delivery to Multi-Target Synergistic Enhancement

Unlike traditional delivery systems that focus solely on encapsulation efficiency and stability, cBioMey’s rare ginsenoside delivery module also possesses multi-target capabilities. Through its self-developed functional database and pathway-mapping platform, the research team systematically correlated various rare ginsenosides with pathways involved in skin barrier repair, inflammation regulation, follicular microenvironment homeostasis, and neuroendocrine function.

In this system, the delivery module itself can participate in the skin’s biological processes, forming a synergistic effect with the loaded active ingredients rather than functioning as a single inert carrier. This mechanism enables the platform to broadly accommodate various high-value active ingredients, including peptides, fermentation-derived active substances, and highly polar functional molecules, achieving an integrated upgrade of “delivery and enhancement.”

Platform-Based Path from Molecular Mechanism to Clinical Validation

cBioMey treats all combinations of delivery modules and active substances as independent research subjects, conducting systematic evaluations according to drug development logic: from target identification, transmembrane efficiency assessment, and cellular pathway validation, to three-dimensional skin models and human efficacy testing, ultimately entering the clinical evaluation system of tertiary hospitals.

As a benchmark case specifically designed for anti-hair loss, this product is based on a rare ginsenoside nano-delivery module, incorporating anti-hair loss functional molecules selected from the ginsenoside system. Under the standard evaluation system for cellular experiments and clinical studies, its overall efficacy demonstrates superior trends in certain biological indicators compared to the 5 % minoxidil control.

This result validates that replacing traditional carrier systems with naturally derived delivery modules can achieve functional performance comparable to or even surpassing that of classical pharmaceutical actives.

Upgrading Platform for High-Value Active Substances

The delivery system has been used in numerous high-efficacy skincare and raw material collaboration projects. In a project request from Botanee, China’s premier functional cosmetics brand, it’s aimed at developing an encapsulation solution for a high-value, highly sensitive peptide-based active ingredient. cBioMey’s ginseng-based encapsulation system demonstrated superior encapsulation stability, transdermal diffusion efficiency, and terminal efficacy conversion compared to domestic alternatives. The products have achieved over one million actual usage verifications after market launch.

There is another real case. Changfa YAO conducted in-depth research into the secret behind the long hair of a village recognized by the Guinness World Records and discovered that it was due to a unique fermented agent. This fermentation agent comprises complex active components with poor stability and significant individual variability in efficacy. Through a standardized carrier system centered on a rare ginsenoside delivery module, key functional molecules are effectively protected and stably delivered to the hair follicle microenvironment, resulting in more significant and consistent anti-hair loss effects. Within three years, the company emerged as a leading anti-hair loss brand in China.

Redefining the Core Logic of Active Material Upgrading

cBioMey maintains that upgrading bioactive compounds should not focus solely on identifying ‘stronger molecules,’ but rather on the fundamental biological infrastructure of delivery systems to address how molecules enter authentic biological pathways.

The construction of a delivery system using ginseng-derived molecules to replace cholesterol not only represents an innovative material with enhanced biocompatibility, but establishes a scalable upgrade platform that enables stable amplification of various high-value bioactive compounds within a unified biological framework.

This is precisely the fundamental reason why cBioMey’s BISD platform is recognized as the ‘Top Active Ingredient Upgrade Customization Platform in Asia 2026.’ It does not merely alter the performance of a single component, but rather transforms the manner in which active ingredients engage in skin biological processes.